U.S. approves gene therapy treatment for hemophilia

26 avril 2024 | Agence France-Presse
Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
 Site référencé:  Raw Story

Raw Story 

Megabill moments from passing after House pushes through drama-filled night
3/07/2025
Alligator Alcatraz has troubling echoes — of Dachau
3/07/2025
'MAGA is not happy !' Trump fumes at GOP over stalled megabill
3/07/2025
'You're never coming back' : Fox host shames GOP defectors as Trump bill in doubt
3/07/2025
'Technically world war' : UK's ex-foreign secretary gives ominous Trump warning
3/07/2025
'Suicidal' : Ex-GOP Speaker blasts Republican holdouts on Trump's budget
3/07/2025